跳至主要内容
临床试验/CTRI/2022/03/041164
CTRI/2022/03/041164尚未招募2 期

efficacy of Agastya haritaki Avaleha as an Immuno - Modulator in Reccurent URTI of Children- A Randomized open clinical trial

PLRD Hospial0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • The cases of recurrent URTI with the features mentioned in the criteria of selection of patients shall be included
  • patients irrespective of sex occupation religion socio economic status and duration of illness
  • children aged between 3-12 years will be included for study
  • Recurrent URT infection with need of antibiotic for 3 times in last six months

排除标准

  • patients above 12 years will be excluded from the study
  • patient with nasal anatomical abnormalities will be excluded
  • patient suffering from chronic systemic disease like tuberculosis and immuno compromised patients

研究者

发起方
PLRD Hospial

相似试验